Management Of Respiratory Failure In COVID Patients



Management Of Respiratory Failure In COVID Patients

It’s been more than 8 months now and still, the COVID-19 pandemic shows no sign of decline in the number of cases.

What makes the COVID-19 pandemic a major cause of concern is the high risk of mortality associated with it, particularly due to respiratory failure.

COVID-19 has a higher tropism for the lung and is known to cause severe pneumonia and ARDS (acute respiratory distress syndrome), especially in patients with a weak immune system and existing co-morbidities.

This marks the need for the physicians, nurses, and healthcare workers to stay abreast of the latest information about the risk of ARDS and the recommended protocol for the management of respiratory distress in COVID-19 patients.

Clinical features of ARDS in COVID-19 patents

Most patients with COVID-induced respiratory distress meet the Berlin definition of ARDS. However, some patients may exhibit a different phenotype of ARDS with lower lung weight, higher lung compliance, and a marked dissociation between the preservation of lung mechanics and the relative severity of hypoxemia.

These variations can make it difficult for healthcare practitioners to detect respiratory distress before the symptoms have progressed considerably. Hence, physicians and healthcare workers need to be aware of the variations in the early warning signs of ARDS so that it can be detected before serious complications arise.

Treatment of respiratory failure in COVID-19 patients

The treatment of respiratory failure involves intensive therapies including:

·         High flow nasal oxygen therapy

·         Antibiotics

·         Non-invasive ventilation

·         Neuromuscular blockade

·         Mechanical ventilation

·         Prone positioning

·         Tracheostomy

·         Nebulisation

·         Suctioning

·         Bronchoscopy

·         Fluid management

·         Liberation from mechanical ventilation

·         Rescue therapies

Being aware of the treatment protocol is essential for doctors to be able to provide immediate care and support to patients and prevent the risk of mortality.

The treatment may depend on the specific symptoms of the patient, as well as his or her age, general health, and existing morbidities.

Above all, it is also essential for healthcare workers to follow the norms to protect themselves and prevent the spread of this virus while treating patients. This makes it even more difficult for medical practitioners to treat patients in the event of respiratory failure.

There has been a growing concern among the medical fraternity about the rising number of deaths due to respiratory failure and the risks faced by themselves due to the highly contagious nature of the infection.

Now you have an opportunity to discuss all your concerns with expert physicians and learn the latest protocols to manage ARDS.

Physicians, nurses, and other healthcare practitioners are urged to join the webinar on the COVID-19 pandemic on 30th September 2020 between 3 pm to 8 pm. You will learn everything you need to know about COVID-19 including its evolution, epidemiology, pathophysiology, treatment, vaccinations, and much more.

You can also ask questions and interact with our panel of expert physicians so that you can take better care of your patients while also protecting yourself against the infection. 


Location: 12 Sarah Ln, East Stroudsburg, PA 18302, USA

Popular posts from this blog

What Is the Endocannabinoid System and What Is Its Role?

Image
  The endocannabinoid system (ECS) refers to a unique molecular system that is responsible for balancing and regulating several physiological processes in the body such as immune response, appetite, communication between cells, metabolism, and memory. Through this system, cannabinoids can interact with the metabolic enzymes and receptors in the body to trigger the therapeutic effects. In spite of the integral role played by the endocannabinoid system in our body, it was discovered only recently. The importance of the endocannabinoid system is also being understood by researchers and the medical community only in the past few decades. The ECS involves 3 basic components: endocannabinoids, enzymes, and receptors. Contrary to what most people believe, these 3 components of ECS are active in the body even when a person does not use cannabis or CBD oils. This marks why it is important to be aware of the role of ECS and the therapeutic benefits it offers to regulate the physiolog...
Read more

COVID-19 Pandemic Treatments, Vaccinations, And Herd Immunity

Image
COVID-19 Pandemic Treatments, Vaccinations, And Herd Immunit y   As the number of COVID-19 cases continues to rise across the world, everyone including patients, physicians, nurses, and healthcare workers are awaiting vaccines that might finally put an end to this challenging phase. There has also been a lot of discussion about herd immunity and how it would change the course of this pandemic. Most of us have our hopes pinned on herd immunity at least until vaccinations are made available. But what exactly is herd immunity and how it develops? Also, once we have it, will it really diminish the spread of this virus and reduce the need for social distancing and masks? These are the topmost questions in the minds of people. Let's find answers to what herb immunity actually means. What is herd immunity? Herd immunity is formed when enough patients have developed immunity to any specific infectious disease such that further community transmission is significantly reduced o...
Read more

Pulmonary Infectious Diseases

Image
  CLICK HERE TO JOIN ME Lung and airway infections are commonly referred to as pulmonary or respiratory infections. Chronic bronchitis, COPD, influenza, tuberculosis, and pneumonia are some of the major forms of respiratory infections.  Nasopharyngeal infections that result in nasal discharge, bronchitis that leads to cough and sputum, and pneumonia that leads to cough with sputum can also increase the respiratory rate and lead to breathing difficulties.  There are several viruses that contribute to the increased incidence of bronchitis, while bacteria are known to contribute to pneumonia.  These infections usually spread from infected patients to healthy people through contaminated droplets released into the air when the infected person sneezes and coughs. These respiratory conditions are the leading causes of mortality and morbidity from infectious diseases across the world. Nearly four million people are estimated to die due to acute respiratory infection every ye...
Read more